Cytokinetics Inc CYTK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:00 AM EDT
26.21quote price arrow up+0.21 (+0.81%)
Volume
200,568
52 week range
13.87 - 30.14

...

Loading . . .
  • Open26.09
  • Day High26.26
  • Day Low25.67
  • Prev Close26.00
  • 52 Week High30.14
  • 52 Week High Date10/05/20
  • 52 Week Low13.87
  • 52 Week Low Date05/01/20

Key Stats

  • Market Cap1.875B
  • Shares Out71.54M
  • 10 Day Average Volume0.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.37
  • YTD % Change25.94

KEY STATS

  • Open26.09
  • Day High26.26
  • Day Low25.67
  • Prev Close26.00
  • 52 Week High30.14
  • 52 Week High Date10/05/20
  • 52 Week Low13.87
  • 52 Week Low Date05/01/20
  • Market Cap1.875B
  • Shares Out71.54M
  • 10 Day Average Volume0.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.37
  • YTD % Change25.94

RATIOS/PROFITABILITY

  • EPS (TTM)-2.08
  • P/E (TTM)-12.62
  • Fwd P/E (NTM)-10.34
  • EBITDA (MRQ)-92.112M
  • ROE (MRQ)-248.50%
  • Revenue (MRQ)55.83M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-228.00%
  • Debt To Equity (MRQ)119.69%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Cytokinetics Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. It is focused on the discovery and development of small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. The Company is developing small...
Leonard Patrick Gage Ph.D.
Chairman
Robert Blum
Chief Executive Officer
Ching Jaw
Chief Financial Officer
Robert Wong
Chief Accounting Officer
Fady Malik M.D., Ph.D.
Executive Vice President
Address
280 E Grand Ave
South San Francisco, CA
94080-4808
United States

Top Peers

SYMBOLLASTCHG%CHG
MORF
Morphic Holding Inc
55.67-0.77-1.37%
MYOV
Myovant Sciences Ltd
19.48UNCHUNCH
MCRB
Seres Therapeutics Inc
20.44-0.26-1.26%
NGM
NGM Biopharmaceuticals Inc
26.83-0.23-0.85%
HRTX
Heron Therapeutics Inc
17.91-0.17-0.94%